UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial

Diabetes care, 2000-12, Vol.23 (12), p.1823-1829

2000

Link zum Volltext

Verfügbarkeit prüfen

Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent

The Journal of pharmacology and experimental therapeutics, 1990-02, Vol.252 (2), p.711

1990

Link zum Volltext

Verfügbarkeit prüfen

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent

The Journal of pharmacology and experimental therapeutics, 1990-10, Vol.255 (1), p.211

1990

Link zum Volltext

Verfügbarkeit prüfen

Hypotensive Action of DuP 753, an Angiotensin II Antagonist, in Spontaneously Hypertensive Rats Nonpeptide Angiotensin II Receptor Antagonists: X

Hypertension (Dallas, Tex. 1979), 1990-05, Vol.15 (5), p.459-468

1990

Link zum Volltext

Verfügbarkeit prüfen

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

Diabetic medicine, 1998-10, Vol.15 (10), p.821-825

1998

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically III patients

Chest, 2003-09, Vol.124 (3), p.1030-1038

2003

Link zum Volltext

Verfügbarkeit prüfen

Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent

The Journal of pharmacology and experimental therapeutics, 1990-02, Vol.252 (2), p.719

1990

Link zum Volltext

Verfügbarkeit prüfen

Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies

The Journal of pharmacology and experimental therapeutics, 1989-09, Vol.250 (3), p.867

1989

Link zum Volltext

Verfügbarkeit prüfen

Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent

The Journal of pharmacology and experimental therapeutics, 1990-02, Vol.252 (2), p.726

1990

Link zum Volltext

Verfügbarkeit prüfen

The hypoxia-selective cytotoxin NLCQ-I (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy

British journal of cancer, 2010, Vol.103 (2), p.201-208

2010

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacology of DuP 753

American journal of hypertension, 1991-04, Vol.4 (4-Pt-2), p.288S-298S

1991

Link zum Volltext

Verfügbarkeit prüfen

Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307)

The Journal of pharmacology and experimental therapeutics, 1988-10, Vol.247 (1), p.1

1988

Link zum Volltext

Verfügbarkeit prüfen

Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimi-dinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors

Bioorganic & medicinal chemistry letters, 2009, Vol.19 (15), p.4504-4508

2009

Link zum Volltext

Verfügbarkeit prüfen

The Influence of Crystal Habit on the Prediction of Dry Powder Inhalation Formulation Performance Using the Cohesive-Adhesive Force Balance Approach: Innovative Inhalation Technologies

Drug development and industrial pharmacy, 2008, Vol.34 (9), p.974-983

2008

Link zum Volltext

Verfügbarkeit prüfen

Non-peptide angiotensin II receptor antagonists. II . Pharmacology of S-8308

European journal of pharmacology, 1988-11, Vol.157 (1), p.13-21

1988

Link zum Volltext

Verfügbarkeit prüfen

Phenylacetamides as selective α-1A adrenergic receptor antagonists

Bioorganic & medicinal chemistry letters, 2000-08, Vol.10 (15), p.1621-1624

2000

Link zum Volltext

Verfügbarkeit prüfen

Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint

Clinical cancer research, 1996-02, Vol.2 (2), p.269-276

1996

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Pharmacology of DuP 753

American journal of hypertension, 1991-04, Vol.4 (4-Pt-2), p.282S-287S

1991

Link zum Volltext

Verfügbarkeit prüfen

Augmentation of Antiproliferative Activity of Interferon Alfa Against Human Bladder Tumor Cell Lines by Encapsulation of Interferon Alfa Within Liposomes

JNCI : Journal of the National Cancer Institute, 1989-09, Vol.81 (18), p.1387-1392

1989

Link zum Volltext

Verfügbarkeit prüfen

The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors

The Journal of pharmacology and experimental therapeutics, 1994-03, Vol.268 (3), p.1499

1994

Link zum Volltext

Verfügbarkeit prüfen

Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study

Gut, 1995-08, Vol.37 (2), p.195-198

1995

Link zum Volltext

Verfügbarkeit prüfen

Second Generation Leukotriene B4 Receptor Antagonists Related to SC-41930: Heterocyclic Replacement of the Methyl Ketone Pharmacophore

Journal of medicinal chemistry, 1995-03, Vol.38 (6), p.858-868

1995

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

Journal of clinical oncology, 1998-01, Vol.16 (1), p.229-236

1998

Link zum Volltext

Verfügbarkeit prüfen

United Kingdom multicentre clinical trial of somatrem

Archives of disease in childhood, 1987-08, Vol.62 (8), p.776-779

1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink_现刊

ThemaScience & Technology

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(45)
Tagungsberichte
(6)

Sprache

Englisch
(51)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(51)
Medical Sciences
(51)
Animals
(16)
Male
(15)
Cardiovascular System
(14)
Antihypertensive Agents
(13)
Humans
(13)
Rats
(13)
Imidazoles - Pharmacology
(10)
In Vitro Techniques
(10)
Angiotensin Ii - Antagonists & Inhibitors
(9)
Female
(8)
Rats, Inbred Strains
(8)
Angiotensin Receptor Antagonists
(7)
Losartan
(7)
Receptors, Angiotensin - Drug Effects
(7)
Tetrazoles - Pharmacology
(7)
Administration, Oral
(5)
Adult
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial

Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent

Hypotensive Action of DuP 753, an Angiotensin II Antagonist, in Spontaneously Hypertensive Rats Nonpeptide Angiotensin II Receptor Antagonists: X

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically III patients

Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent

Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies

Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent

The hypoxia-selective cytotoxin NLCQ-I (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy

In Vivo Pharmacology of DuP 753

Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307)

Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimi-dinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors

The Influence of Crystal Habit on the Prediction of Dry Powder Inhalation Formulation Performance Using the Cohesive-Adhesive Force Balance Approach: Innovative Inhalation Technologies

Non-peptide angiotensin II receptor antagonists. II . Pharmacology of S-8308

Phenylacetamides as selective α-1A adrenergic receptor antagonists

Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint

In Vitro Pharmacology of DuP 753

The Selective 5-HT1B Receptor Inverse Agonist 1‘-Methyl-5-[[2‘-methyl-4‘- (5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4‘-piperidine] (SB-224289) Potently Blocks Terminal 5-HT Autoreceptor Function Both in Vitro and in Vivo

Augmentation of Antiproliferative Activity of Interferon Alfa Against Human Bladder Tumor Cell Lines by Encapsulation of Interferon Alfa Within Liposomes

The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors

Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study

Second Generation Leukotriene B4 Receptor Antagonists Related to SC-41930: Heterocyclic Replacement of the Methyl Ketone Pharmacophore

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

United Kingdom multicentre clinical trial of somatrem

Aktive Filter

Suchergebnisse filtern